{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:06:51Z","timestamp":1792822011305,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Promedius"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00198-026-07858-1","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:15:49Z","timestamp":1769004949000},"page":"717-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and economic impact of deep learning-enhanced opportunistic osteoporosis screening using chest radiographs with and without the osteoporosis self-assessment tool for Asians (OSTA)"],"prefix":"10.1007","volume":"37","author":[{"given":"Manju","family":"Chandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4274-9258","authenticated-orcid":false,"given":"Mickael","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"7858_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882241","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen Y, Huang X, Wu J, Lin X, Zhou X, Zhu Z et al (2022) The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990\u20132019. Front Endocrinol (Lausanne) 13:882241","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7858_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M et al (2021) Scope 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16(1):82","journal-title":"Arch Osteoporos"},{"issue":"1","key":"7858_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-019-0664-4","volume":"14","author":"M Chandran","year":"2019","unstructured":"Chandran M, Lau TC, Gagnon-Arpin I, Dobrescu A, Li W, Leung MYM et al (2019) The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options. Arch Osteoporos 14(1):114","journal-title":"Arch Osteoporos"},{"issue":"8","key":"7858_CR4","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s00198-005-0051-4","volume":"17","author":"SP Chan","year":"2006","unstructured":"Chan SP, Teo CC, Ng SA, Goh N, Tan C, Deurenberg-Yap M (2006) Validation of various osteoporosis risk indices in elderly Chinese females in Singapore. Osteoporos Int 17(8):1182\u20131188","journal-title":"Osteoporos Int"},{"issue":"10","key":"7858_CR5","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00198-024-07179-1","volume":"35","author":"A Paderno","year":"2024","unstructured":"Paderno A, Ataide Gomes EJ, Gilberg L, Maerkisch L, Teodorescu B, Koc AM, Meyer M (2024) Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping review. Osteoporos Int 35(10):1681\u20131692","journal-title":"Osteoporos Int"},{"issue":"2","key":"7858_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/jbmr.4477","volume":"37","author":"M Jang","year":"2022","unstructured":"Jang M, Kim M, Bae SJ, Lee SH, Koh JM, Kim N (2022) Opportunistic osteoporosis screening using chest radiographs with deep learning: development and external validation with a cohort dataset. J Bone Miner Res 37(2):369\u2013377","journal-title":"J Bone Miner Res"},{"issue":"4","key":"7858_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jacr.2023.07.024","volume":"21","author":"A Bilbily","year":"2024","unstructured":"Bilbily A, Syme CA, Adachi JD, Berger C, Morin SN, Goltzman D, Cicero MD (2024) Opportunistic screening of low bone mineral density from standard X-rays. J Am Coll Radiol 21(4):633\u2013639","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"7858_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40520-025-03048-x","volume":"37","author":"JY Reginster","year":"2025","unstructured":"Reginster JY, Schmidmaier R, Alokail M, Hiligsmann M (2025) Cost-effectiveness of opportunistic osteoporosis screening using chest radiographs with deep learning in Germany. Aging Clin Exp Res 37(1):149","journal-title":"Aging Clin Exp Res"},{"key":"7858_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2025.07.028","author":"M Hiligsmann","year":"2025","unstructured":"Hiligsmann M, Silverman SL, Reginster JY (2025) Cost-effectiveness of opportunistic osteoporosis screening using chest radiographs with deep learning in the United States. J Am Coll Radiol. https:\/\/doi.org\/10.1016\/j.jacr.2025.07.028","journal-title":"J Am Coll Radiol"},{"key":"7858_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.afos.2025.10.003","author":"JY Reginster","year":"2025","unstructured":"Reginster JY, Hamasaki T, Fujiwara S, Alokail M, Hiligsmann M (2025) Cost-effectiveness of opportunistic osteoporosis screening using artificial-intelligence assisted chest radiographs in Japan. Osteoporos Sarcopenia. https:\/\/doi.org\/10.1016\/j.afos.2025.10.003","journal-title":"Osteoporos Sarcopenia"},{"key":"7858_CR11","unstructured":"Agency for Care Effectiveness (Singapore). Drug and vaccine evaluation methods and process guide (Version 3.1). Agency for Care Effectiveness, Ministry of Health, Singapore. 2023"},{"issue":"1","key":"7858_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00198-020-05536-4","volume":"32","author":"M Chandran","year":"2021","unstructured":"Chandran M, Ganesan G, Tan KB, Reginster JY, Hiligsmann M (2021) Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Singaporean women. Osteoporos Int 32(1):133\u2013144","journal-title":"Osteoporos Int"},{"issue":"4","key":"7858_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027049","volume":"9","author":"F Fatoye","year":"2019","unstructured":"Fatoye F, Smith P, Gebrye T, Yeowell G (2019) Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9(4):e027049","journal-title":"BMJ Open"},{"issue":"6","key":"7858_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00256-022-04255-7","volume":"52","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhou R, Luo X, Dai Z, Qu G, Li J et al (2023) Routine chest CT combined with the Osteoporosis Self-Assessment Tool for Asians (OSTA): a screening tool for patients with osteoporosis. Skeletal Radiol 52(6):1169\u20131178","journal-title":"Skeletal Radiol"},{"issue":"6","key":"7858_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13350","volume":"73","author":"MHH Cheen","year":"2019","unstructured":"Cheen MHH, Tan YZ, Oh LF, Wee HL, Thumboo J (2019) Prevalence of and factors associated with primary medication non-adherence in chronic disease: a systematic review and meta-analysis. Int J Clin Pract 73(6):e13350","journal-title":"Int J Clin Pract"},{"issue":"1","key":"7858_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03646-y","volume":"21","author":"KK Chen","year":"2020","unstructured":"Chen KK, Wee SL, Pang BWJ, Lau LK, Jabbar KA, Seah WT et al (2020) Bone mineral density reference values in Singaporean adults and comparisons for osteoporosis establishment-the Yishun study. BMC Musculoskelet Disord 21(1):633","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"7858_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3803\/EnM.2013.28.3.180","volume":"28","author":"J Lee","year":"2013","unstructured":"Lee J, Lee S, Jang S, Ryu OH (2013) Age-related changes in the prevalence of osteoporosis according to gender and skeletal site: the Korea National Health and Nutrition Examination Survey 2008\u20132010. Endocrinol Metab 28(3):180\u2013191","journal-title":"Endocrinol Metab"},{"issue":"4","key":"7858_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00198-019-04839-5","volume":"30","author":"EL Yong","year":"2019","unstructured":"Yong EL, Ganesan G, Kramer MS, Logan S, Lau TC, Cauley JA, Tan KB (2019) Hip fractures in Singapore: ethnic differences and temporal trends in the new millennium. Osteoporos Int 30(4):879\u2013886","journal-title":"Osteoporos Int"},{"issue":"7041","key":"7858_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","volume":"312","author":"D Marshall","year":"1996","unstructured":"Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254\u20131259","journal-title":"BMJ"},{"issue":"2","key":"7858_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00198-003-1516-y","volume":"15","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B (2004) Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 15(2):108\u2013112","journal-title":"Osteoporos Int"},{"issue":"3","key":"7858_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00198-017-4317-4","volume":"29","author":"A Svedbom","year":"2018","unstructured":"Svedbom A, Borgstom F, Hernlund E, Strom O, Alekna V, Bianchi ML et al (2018) Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS. Osteoporos Int 29(3):557\u2013566","journal-title":"Osteoporos Int"},{"key":"7858_CR22","unstructured":"NICE. Bisphosphonates for treating osteoporosis. Technology appraisal guidance [TA464]. Last update: 8 July 2019"},{"issue":"1","key":"7858_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00198-021-06085-0","volume":"33","author":"M Chandran","year":"2022","unstructured":"Chandran M, Hao Y, Kwee AK, Cheen MHH, Chin YA, Ng VYT (2022) Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia. Osteoporos Int 33(1):251\u2013261","journal-title":"Osteoporos Int"},{"key":"7858_CR24","unstructured":"Agency for Care Effectiveness (ACE). Denosumab for treating osteoporosis and glucocorticoid-associated bone loss. Technology Guidance; effective 1 Jul 2022 (Medication Assistance Fund listing)"},{"issue":"8","key":"7858_CR25","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u2013765","journal-title":"N Engl J Med"},{"issue":"3","key":"7858_CR26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00198-011-1635-9","volume":"23","author":"MH Cheen","year":"2012","unstructured":"Cheen MH, Kong MC, Zhang RF, Tee FM, Chandran M (2012) Adherence to osteoporosis medications amongst Singaporean patients. Osteoporos Int 23(3):1053\u20131060","journal-title":"Osteoporos Int"},{"key":"7858_CR27","doi-asserted-by":"crossref","unstructured":"Viswambaram A, Wee YR, Lim S. Is there an implicit willingness-to-pay threshold in Singapore; Value Health Reg Issues; 2020:22, S72. PMU20","DOI":"10.1016\/j.vhri.2020.07.378"},{"key":"7858_CR28","unstructured":"Ministry of Health Singapore. The White Paper on Healthier SG. 21 September 2022. Available at: https:\/\/www.moh.gov.sg\/newsroom\/white-paper-on-healthier-sg. Accessed Nov 2025"},{"issue":"7","key":"7858_CR29","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00198-020-05742-0","volume":"32","author":"M Chandran","year":"2021","unstructured":"Chandran M, Mitchell PJ, Amphansap T, Bhadada SK, Chadha M, Chan DC et al (2021) Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region. Osteoporos Int 32(7):1249\u20131275","journal-title":"Osteoporos Int"},{"issue":"5","key":"7858_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00774-024-01532-4","volume":"42","author":"N Yamamoto","year":"2024","unstructured":"Yamamoto N, Shiroshita A, Kimura R, Kamo T, Ogihara H, Tsuge T (2024) Diagnostic accuracy of chest X-ray and CT using artificial intelligence for osteoporosis: systematic review and meta-analysis. J Bone Miner Metab 42(5):483\u2013491","journal-title":"J Bone Miner Metab"},{"key":"7858_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115286","volume":"134","author":"E Soreskog","year":"2020","unstructured":"Soreskog E, Strom O, Spangeus A, Akesson KE, Borgstrom F, Banefelt J et al (2020) Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older. Bone 134:115286","journal-title":"Bone"},{"issue":"6","key":"7858_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","volume":"152","author":"P Haentjens","year":"2010","unstructured":"Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152(6):380\u2013390","journal-title":"Ann Intern Med"},{"issue":"1","key":"7858_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00198-018-4744-x","volume":"30","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Reginster JY, Tosteson ANA, Bukata SV, Saag KG, Gold DT et al (2019) Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts\u2019 consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation. Osteoporos Int 30(1):45\u201357","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-07858-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-07858-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-07858-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:37:04Z","timestamp":1776245824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-07858-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7858"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-07858-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MC has received honoraria for speaking engagements from Kyowa Kirin and Amgen and travel grants from Amgen. JYR has received consultancy fees from and joined the Speakers Bureau for Echolight, Viatris, Theramex, Promedius and Besins.\u00a0MC and JYR are Scientific Advisor Board members of Promedius. MYK is employee at Promedius Inc., Seoul, Republic of Korea. MH has received research grants (paid to institution) from Angelini Pharma, lecture fees from IBSA (paid to institution) and Echolight, and was grant advisor for Pfizer (paid to institution) and research advisor (paid to institution) for Gr\u00fcnenthal and for Teva. The funder had no access to the dataset and model, and had no role in study design, data collection or analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}